Hosted on MSN4h
Alzheimer’s and Gut Infection; Novel Tau Therapy; Kids’ Brain Structure and Drug Use
The Scientist explored the work of a researcher who had an unexpected finding while developing a novel anti-tau therapy.
STAT1d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
First pill to slow down Alzheimer’s considered for use on NHS
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...
New York Post4d
Five monumental Alzheimer’s discoveries scientists made in 2024
While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in ...
5 major Alzheimer’s discoveries scientists made in 2024
As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...
protothema.gr1d
The new drugs coming in 2025 for obesity, alzheimer’s, cancer, and chronic pain
The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...
Pharmaceutical Technology1d
Ta-1505 by Merck for Alzheimer’s Disease: Likelihood of Approval
Ta-1505 is under clinical development by Merck and currently in Phase I for Alzheimer’s Disease. According to GlobalData, Phase I drugs for Alzheimer’s Disease have a 63% phase transition success rate ...
Breakthroughs in Alzheimer’s research may be game-changers
Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...
Anavex Life Sciences: Jumping In On Time Ahead Of An Early Alzheimer's Decision
Anavex Life Sciences' ANAVEX 2-73 shows promise in treating Alzheimer's, with strong efficacy in slowing cognitive and ...
BioTechniques1d
Microglia revealed as double agents in Alzheimer’s disease progression
Microglia have been revealed to first help spread Alzheimer’s disease pathology across the brain and then activate to limit ...
Science Daily4d
Alzheimer's News
Dec. 19, 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, ... Study Supports New Blood ...